Novaremed AG is a clinical-stage Swiss biopharmaceutical company, HQ in Basel, Switzerland, with a subsidiary in Israel. Novaremed is developing an orally active, first-in-class, small molecule (NRD.E1), with a novel mechanism of action, to treat Diabetic Neuropathic Pain.
View Top Employees from Novaremed AGWebsite | https://www.novaremed.com/ |
Revenue | $3 million |
Employees | 10 (10 on RocketReach) |
Founded | 2017 |
Address | Thiersteinerallee 17, Basel, Basel City 4053, CH |
Phone | +41 79 207 57 15 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Novaremed AG employee's phone or email?
The Novaremed AG annual revenue was $3 million in 2024.
Maurizio Rainisio is the Head of Biometry of Novaremed AG.
10 people are employed at Novaremed AG.
Novaremed AG is based in Basel, Basel City.
The NAICS codes for Novaremed AG are [541, 325, 54, 3254, 32, 32541].
The SIC codes for Novaremed AG are [28, 283].